Back
Myriad Genetics Stock Price Chart
Sponsored
MYGN
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
MYGN
Myriad Genetics
Last Price:
15.04
Seasonality Move:
18.24%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Myriad Genetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.71 | Sell |
20-day SMA: | 18.2 | Sell |
50-day SMA: | 22.79 | Sell |
200-day SMA: | 23.48 | Sell |
8-day EMA: | 15.86 | Sell |
20-day EMA: | 17.95 | Sell |
50-day EMA: | 21.27 | Sell |
200-day EMA: | 22.98 | Sell |
Myriad Genetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.29 | Sell |
Relative Strength Index (14 RSI): | 19.49 | Sell |
Chaikin Money Flow: | 619490 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.08 - 22.24) | Sell |
Bollinger Bands (100): | (21.09 - 28.73) | Sell |
Myriad Genetics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Myriad Genetics Stock
Is Myriad Genetics Stock a Buy?
- Myriad Genetics share price is 15.30 while MYGN 8-day simple moving average is 15.71, which is a Sell signal.
- The stock price of MYGN is 15.30 while Myriad Genetics 20-day SMA is 18.20, which makes it a Sell.
- Myriad Genetics 50-day simple moving average is 22.79 while MYGN share price is 15.30, making it a Sell technically.
- MYGN stock price is 15.30 and Myriad Genetics 200-day simple moving average is 23.48, creating a Sell signal.
MYGN Technical Analysis vs Fundamental Analysis
Sell
16
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy or a Sell?
-
Myriad Genetics stock is rated a Sell
The current Myriad Genetics [MYGN] share price is $15.30. The Score for MYGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Myriad Genetics Stock Info
Market Cap:
1.39B
Price in USD:
15.30
Share Volume:
687.07K
Myriad Genetics 52-Week Range
52-Week High:
29.30
52-Week Low:
14.91
Sell
16
Myriad Genetics (MYGN)
is a Sell
Myriad Genetics Share Price Forecast
-
What is the Myriad Genetics stock price today?
The Myriad Genetics stock price is 15.30 USD today. -
Will MYGN stock go up or go down?
Myriad Genetics> share price is forecast to RISE/FALL based on technical indicators -
Is Myriad Genetics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Myriad Genetics is overvalued.
Is Myriad Genetics Stock a Buy?
- Myriad Genetics share price is 15.30 while MYGN 8-day exponential moving average is 15.86, which is a Sell signal.
- The stock price of MYGN is 15.30 while Myriad Genetics 20-day EMA is 17.95, which makes it a Sell.
- Myriad Genetics 50-day exponential moving average is 21.27 while MYGN share price is 15.30, making it a Sell technically.
- MYGN stock price is 15.30 and Myriad Genetics 200-day simple moving average is 22.98, creating a Sell signal.
Fundamental Analysis of Myriad Genetics
Is Myriad Genetics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.00 per share.
Technical Analysis of Myriad Genetics
Should I short Myriad Genetics stock?
- MYGN Moving Average Covergence Divergence (MACD) indicator is -2.29, suggesting Myriad Genetics is a Sell
- Myriad Genetics Relative Strength Index (RSI) is 19.49, which suggest Myriad Genetics is oversold
- The Bollinger Bands (25) for Myriad Genetics is (16.08 - 22.24), which suggest Myriad Genetics is a Sell
- The Bollinger Bands (100) for Myriad Genetics is (21.09 - 28.73), which suggest Myriad Genetics is a Sell
* Myriad Genetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.